AAC -- Table of Contents (March 1 1996, 40 [3])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Contents: March 1996, Volume 40, Issue 3

       Minireviews

       Articles

       Letters

Other Issues

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Minireviews:

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription
EJ Arts and MA Wainberg
Antimicrob. Agents Chemother. March 1996 40: 527-540;
[PDF] [Reprints and Permissions]

Articles:

Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine
Y Wang and A Casadevall
Antimicrob. Agents Chemother. March 1996 40: 541-545;
[Abstract] [PDF] [Reprints and Permissions]

Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice
LE Bermudez, CB Inderlied, P Kolonoski, M Wu, L Barbara-Burnham, and LS Young
Antimicrob. Agents Chemother. March 1996 40: 546-551;
[Abstract] [PDF] [Reprints and Permissions]

Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide
J Dhillon, JM Dickinson, K Sole, and DA Mitchison
Antimicrob. Agents Chemother. March 1996 40: 552-555;
[Abstract] [PDF] [Reprints and Permissions]

Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients
R Dixon, AL Pozniak, HM Watt, P Rolan, and J Posner
Antimicrob. Agents Chemother. March 1996 40: 556-560;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys
R Teng, D Girard, TD Gootz, G Foulds, and TE Liston
Antimicrob. Agents Chemother. March 1996 40: 561-566;
[Abstract] [PDF] [Reprints and Permissions]

Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants [published erratum appears in Antimicrob Agents Chemother 1996 Jul;40(7):1757]
WL Hayton, J Kneer, R de Groot, and K Stoeckel
Antimicrob. Agents Chemother. March 1996 40: 567-574;
[Abstract] [PDF] [Reprints and Permissions]

Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies
BG Reigner and HA Welker
Antimicrob. Agents Chemother. March 1996 40: 575-580;
[Abstract] [PDF] [Reprints and Permissions]

The macrolide-lincosamide-streptogramin B resistance phenotypes characterized by using a specifically deleted, antibiotic-sensitive strain of Streptomyces lividans
JL Pernodet, S Fish, MH Blondelet-Rouault, and E Cundliffe
Antimicrob. Agents Chemother. March 1996 40: 581-585;
[Abstract] [PDF] [Reprints and Permissions]

Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis
HW Murray and J Hariprashad
Antimicrob. Agents Chemother. March 1996 40: 586-587;
[Abstract] [PDF] [Reprints and Permissions]

Susceptibilities of Candida spp. to antifungal agents visualized by two- dimensional scatterplots of relative growth
FC Odds, G Dams, G Just, and P Lewi
Antimicrob. Agents Chemother. March 1996 40: 588-594;
[Abstract] [PDF] [Reprints and Permissions]

Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae
CK Lee, M Minami, S Sakuda, T Nihira, and Y Yamada
Antimicrob. Agents Chemother. March 1996 40: 595-601;
[Abstract] [PDF] [Reprints and Permissions]

Differential in vitro activities of ionophore compounds against Plasmodium falciparum and mammalian cells
C Gumila, ML Ancelin, G Jeminet, AM Delort, G Miquel, and HJ Vial
Antimicrob. Agents Chemother. March 1996 40: 602-608;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia
A Ayestaran, RM Lopez, JB Montoro, A Estibalez, L Pou, A Julia, A Lopez, and B Pascual
Antimicrob. Agents Chemother. March 1996 40: 609-612;
[Abstract] [PDF] [Reprints and Permissions]

Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis
E Chiari, AB Oliveira, MA Prado, RJ Alves, LM Galvao, and FG Araujo
Antimicrob. Agents Chemother. March 1996 40: 613-615;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase
A Bauernfeind, I Stemplinger, R Jungwirth, P Mangold, S Amann, E Akalin, O Ang, C Bal, and JM Casellas
Antimicrob. Agents Chemother. March 1996 40: 616-620;
[Abstract] [PDF] [Reprints and Permissions]

In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions
JE Sjostrom, J Fryklund, T Kuhler, and H Larsson
Antimicrob. Agents Chemother. March 1996 40: 621-626;
[Abstract] [PDF] [Reprints and Permissions]

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model
KJ Madaras-Kelly, BE Ostergaard, LB Hovde, and JC Rotschafer
Antimicrob. Agents Chemother. March 1996 40: 627-632;
[Abstract] [PDF] [Reprints and Permissions]

Antituberculosis activities of clofazimine and its new analogs B4154 and B4157
VM Reddy, G Nadadhur, D Daneluzzi, JF O'Sullivan, and PR Gangadharam
Antimicrob. Agents Chemother. March 1996 40: 633-636;
[Abstract] [PDF] [Reprints and Permissions]

Amphotericin B enzyme-linked immunosorbent assay
JD Cleary, SW Chapman, J Deng, and CJ Lobb
Antimicrob. Agents Chemother. March 1996 40: 637-641;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucks
P Rajagopalan, FD Boudinot, CK Chu, BC Tennant, BH Baldwin, and RF Schinazi
Antimicrob. Agents Chemother. March 1996 40: 642-645;
[Abstract] [PDF] [Reprints and Permissions]

Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability
FJ Abadi, PE Carter, P Cash, and TH Pennington
Antimicrob. Agents Chemother. March 1996 40: 646-651;
[Abstract] [PDF] [Reprints and Permissions]

Transport of the antibacterial agent oxazolidin-2-one and derivatives across intestinal (Caco-2) and renal (MDCK) epithelial cell lines
G Ranaldi, P Seneci, W Guba, K Islam, and Y Sambuy
Antimicrob. Agents Chemother. March 1996 40: 652-658;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography
AJ Fischman, E Livni, JW Babich, NM Alpert, A Bonab, S Chodosh, F McGovern, P Kamitsuka, YY Liu, R Cleeland, BL Prosser, JA Correia, and RH Rubin
Antimicrob. Agents Chemother. March 1996 40: 659-664;
[Abstract] [PDF] [Reprints and Permissions]

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome- encapsulated tobramycin in an animal model of chronic pulmonary infection
C Beaulac, S Clement-Major, J Hawari, and J Lagace
Antimicrob. Agents Chemother. March 1996 40: 665-669;
[Abstract] [PDF] [Reprints and Permissions]

Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats
D Beauchamp, P Collin, L Grenier, M LeBrun, M Couture, L Thibault, G Labrecque, and MG Bergeron
Antimicrob. Agents Chemother. March 1996 40: 670-676;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
DM Cappelletty and MJ Rybak
Antimicrob. Agents Chemother. March 1996 40: 677-683;
[Abstract] [PDF] [Reprints and Permissions]

Activity and mode of action of acridine compounds against Leishmania donovani
CM Mesa-Valle, J Castilla-Calvente, M Sanchez-Moreno, V Moraleda-Lindez, J Barbe, and A Osuna
Antimicrob. Agents Chemother. March 1996 40: 684-690;
[Abstract] [PDF] [Reprints and Permissions]

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections
AS Benko, DM Cappelletty, JA Kruse, and MJ Rybak
Antimicrob. Agents Chemother. March 1996 40: 691-695;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
JK James, SM Palmer, DP Levine, and MJ Rybak
Antimicrob. Agents Chemother. March 1996 40: 696-700;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots
SM Palmer and MJ Rybak
Antimicrob. Agents Chemother. March 1996 40: 701-705;
[Abstract] [PDF] [Reprints and Permissions]

Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi
KM Slunt, JM Grace, TL Macdonald, and RD Pearson
Antimicrob. Agents Chemother. March 1996 40: 706-709;
[Abstract] [PDF] [Reprints and Permissions]

Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
Y Kumagai, JI Kato, K Hoshino, T Akasaka, K Sato, and H Ikeda
Antimicrob. Agents Chemother. March 1996 40: 710-714;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates
M Perilli, A Felici, A Oratore, G Cornaglia, G Bonfiglio, GM Rossolini, and G Amicosante
Antimicrob. Agents Chemother. March 1996 40: 715-719;
[Abstract] [PDF] [Reprints and Permissions]

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones
RN Jones, DM Johnson, and ME Erwin
Antimicrob. Agents Chemother. March 1996 40: 720-726;
[Abstract] [PDF] [Reprints and Permissions]

Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium
LC Chio, LA Bolyard, M Nasr, and SF Queener
Antimicrob. Agents Chemother. March 1996 40: 727-733;
[Abstract] [PDF] [Reprints and Permissions]

Predictors of effect of ampicillin-sulbactam against TEM-1 beta- lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC
AA Firsov, D Savarino, M Ruble, D Gilbert, B Manzano, AA Medeiros, and SH Zinner
Antimicrob. Agents Chemother. March 1996 40: 734-738;
[Abstract] [PDF] [Reprints and Permissions]

Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes
M Ozaki, K Komori, M Matsuda, R Yamaguchi, T Honmura, Y Tomii, I Nishimura, and T Nishino
Antimicrob. Agents Chemother. March 1996 40: 739-742;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium
DM Yajko, CA Sanders, JJ Madej, VL Cawthon, and WK Hadley
Antimicrob. Agents Chemother. March 1996 40: 743-749;
[Abstract] [PDF] [Reprints and Permissions]

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry
R Datema, L Rabin, M Hincenbergs, MB Moreno, S Warren, V Linquist, B Rosenwirth, J Seifert, and JM McCune
Antimicrob. Agents Chemother. March 1996 40: 750-754;
[Abstract] [PDF] [Reprints and Permissions]

Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds
L Rabin, M Hincenbergs, MB Moreno, S Warren, V Linquist, R Datema, B Charpiot, J Seifert, H Kaneshima, and JM McCune
Antimicrob. Agents Chemother. March 1996 40: 755-762;
[Abstract] [PDF] [Reprints and Permissions]

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies
R Nau, HW Prange, M Kinzig, A Frank, A Dressel, P Scholz, H Kolenda, and F Sorgel
Antimicrob. Agents Chemother. March 1996 40: 763-766;
[Abstract] [PDF] [Reprints and Permissions]

Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections
GD Morse, MA Fischl, MJ Shelton, MT Borin, MR Driver, M DeRemer, K Lee, and CP Wajszczuk
Antimicrob. Agents Chemother. March 1996 40: 767-771;
[Abstract] [PDF] [Reprints and Permissions]

Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D- ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin- tazobactam, trimethoprim-sulfamethoxazole, and imipenem
SK Spangler, MA Visalli, MR Jacobs, and PC Appelbaum
Antimicrob. Agents Chemother. March 1996 40: 772-775;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci
M Trautmann, M Ruhnke, K Borner, J Wagner, and P Koeppe
Antimicrob. Agents Chemother. March 1996 40: 776-779;
[Abstract] [PDF] [Reprints and Permissions]

Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state
K Stoeckel, M Harell, and M Dan
Antimicrob. Agents Chemother. March 1996 40: 780-783;
[Abstract] [PDF] [Reprints and Permissions]

Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model
JG den Hollander, JW Mouton, MP van Goor, FP Vleggaar, and HA Verbrugh
Antimicrob. Agents Chemother. March 1996 40: 784-786;
[Abstract] [PDF] [Reprints and Permissions]

Penetration of ciprofloxacin and fleroxacin into biliary tract
CE Edmiston, Jr, EC Suarez, AP Walker, MP Demeure, CT Frantzides, WJ Schulte, and SD Wilson
Antimicrob. Agents Chemother. March 1996 40: 787-791;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers
JS Bertino, Jr and AN Nafziger
Antimicrob. Agents Chemother. March 1996 40: 789-791;
[Abstract] [PDF] [Reprints and Permissions]

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'- fluoroguanosine in vitro and in vivo
P Hafkemeyer, A Keppler-Hafkemeyer, MA al Haya, M von Janta-Lipinski, E Matthes, C Lehmann, WB Offensperger, S Offensperger, W Gerok, and HE Blum
Antimicrob. Agents Chemother. March 1996 40: 792-794;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus
JG Sundelof, R Thompson, KM White, MW Sasor, L Cama, and H Kropp
Antimicrob. Agents Chemother. March 1996 40: 795-798;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis
GW Kaatz and SM Seo
Antimicrob. Agents Chemother. March 1996 40: 799-801;
[Abstract] [PDF] [Reprints and Permissions]

Temporal variation in nephrotoxicity of low doses of isepamicin in rats
Y Yoshiyama, L Grenier, P Gourde, M Simard, L Lin, NJ Morin, MG Bergeron, G Labrecque, and D Beauchamp
Antimicrob. Agents Chemother. March 1996 40: 802-806;
[Abstract] [PDF] [Reprints and Permissions]

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem
JE Hoppe, E Rahimi-Galougahi, and G Seibert
Antimicrob. Agents Chemother. March 1996 40: 807-808;
[Abstract] [PDF] [Reprints and Permissions]

Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis
D Vermot, JM Entenza, J Vouillamoz, MP Glauser, and P Moreillon
Antimicrob. Agents Chemother. March 1996 40: 809-811;
[Abstract] [PDF] [Reprints and Permissions]

Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans
C Martin, X Viviand, M Alaya, F Lokiec, K Ennabli, R Said, and M Pecking
Antimicrob. Agents Chemother. March 1996 40: 812-815;
[Abstract] [PDF] [Reprints and Permissions]

Bleomycin therapy of experimental disseminated candidiasis in mice
JR Graybill, R Bocanegra, A Fothergill, and MG Rinaldi
Antimicrob. Agents Chemother. March 1996 40: 816-818;
[Abstract] [PDF] [Reprints and Permissions]

Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics
O Mimoz, A Jacolot, C Padoin, J Quillard, M Tod, K Louchahi, K Samii, and O Petitjean
Antimicrob. Agents Chemother. March 1996 40: 819-821;
[Abstract] [PDF] [Reprints and Permissions]

In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs
SP Franzot and JS Hamdan
Antimicrob. Agents Chemother. March 1996 40: 822-824;
[Abstract] [PDF] [Reprints and Permissions]

Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye
S Jaruratanasirikul, R Hortiwakul, T Tantisarasart, N Phuenpathom, and S Tussanasunthornwong
Antimicrob. Agents Chemother. March 1996 40: 825-826;
[Abstract] [PDF] [Reprints and Permissions]

Letters:

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae
S Bhattacharya
Antimicrob. Agents Chemother. March 1996 40: 827-828;
[PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.